Provisio Medical, Inc. - Company Research Report

Company Overview

• Name: Provisio Medical, Inc.

• Mission: To enhance procedural workflows and improve clinical outcomes through the development and commercialization of revolutionary endovascular technologies.

• Founded: Provisio Medical was founded in 2014.

• Founder: The company was founded by Dr. S. Eric Ryan, M.D.

• Key People:

• S. Eric Ryan, MD - Founder and CEO

• George Quinoy - Chief Commercial Officer

• John Blake - Chief Financial Officer

• David Goodman - VP, Global Marketing

• Robert Ashley - VP, Regulatory, Quality and Clinical Strategy

• Headquarters: 10815 Rancho Bernardo Road, Suite 110, San Diego, CA 92127

• Number of Employees: No information is available

• Revenue: No information is available

• Company Known For: Market disrupting innovations in vascular and cardiovascular healthcare through the development of technologies like Sonic Lumen Tomography Intravascular Ultrasound (SLT IVUS™).

Products

Sonic Lumen Tomography (SLT) Technology

• Description: Sonic Lumen Tomography technology is a form of Intravascular Ultrasound (IVUS) that provides real-time dimensions of a vessel’s flow lumen without needing user input. It enhances clinical workflows by eliminating the need for using ionizing radiation and kidney-toxic contrast media typically associated with angiography.

SLT IVUS™ P1 System

• Key Features:

• Provides real-time flow lumen vessel dimensions using A-mode (Amplitude mode) ultrasound operation.

• Incorporates ultrasound reflection data similar to SONAR technology to provide accurate information.

SLT IVUS™ Support Crossing Catheter

• Key Features:

• An over-the-wire intravascular ultrasound catheter with an ultrasound transducer array at the distal end to measure the distance from the catheter to the vessel wall.

• Compatibility: Introducer Sheath (5 Fr) and Guidewire (up to 0.018").

• Contains 30 radiopaque markers with 1 cm inked marker spacing.

• Designed for maximum infusion pressure of 300 psi.

Recent Developments

• New Products Launched:

• Introduction of the SLT IVUS™ P1 System and the SLT IVUS™ Support Crossing Catheter, enabling physicians to capture real-time, accurate measurements of vascular flow lumen without image interpretation or delay.

• New Features:

• The SLT IVUS technology is designed for integration into existing endovascular devices, reducing the need for new procedures and promoting cost efficiency with competitive pricing against conventional imaging-only catheters.

• Partnerships:

• Formation of a Physician Advisory Board comprising experts in vascular surgery, interventional radiology, and interventional cardiology, to guide commercialization strategies.

• Key Milestones:

• FDA 510(k) clearance of the Provisio™ SLT IVUS™ System, allowing for new approaches in automatic, real-time, accurate numeric lumen measurements for vascular specialists.

• First commercial clinical cases utilizing the Provisio™ SLT IVUS™ System marked an achievement in real-time vessel measurement influencing treatment decisions.

Conclusion

Provisio Medical continues to advance the standard of care in endovascular procedures through its innovative SLT IVUS technology, providing tangible improvements in clinical workflows and patient outcomes. Their commitment to revolutionizing vascular healthcare is supported by a robust leadership team and strategic partnerships within the medical field. The company remains focused on expanding its impact with cost-efficient solutions that integrate seamlessly into existing medical practices.